DEC 04, 2018 10:41 AM PST

Why is Skin Cancer so Elusive?

WRITTEN BY: Nicholas Breehl

When researchers begin thinking about how to eradicate cancer, they are increasingly considering the immune response and how it’s interplay results in control (in some cases) or the lack of control of the growth. By revealing these immune responses, research teams can identify strengths and weaknesses that can be manipulated, avoided or enhanced to produce a better outcome for the cancer patient and their overall health.

A team of researchers at the Mainz University Medical Center are working to reveal a new signal pathway used by skin cancer cells to evade attacks from the immune system altogether thereby increasing the odds that cancer can survive and thrive.

Skin cancer is defined as the abnormal growth of skin cells most often developing on skin exposed to the sun. Some common forms of skin cancer can also occur in areas of the skin not ordinarily exposed to sunlight. The most common three types of skin cancer include basal cell carcinoma, squamous cell carcinoma, and melanoma. "In our paper in Nature Immunology, we report on a previously unknown immunoevasion mechanism used by the type of skin cancer known as melanoma," said Dr. Toszka Bohn, a researcher at the Institute for Immunology of the Mainz University Medical Center.

Melanoma can develop anywhere on the body, in otherwise normal skin or in an existing mole that becomes cancerous. Melanoma can affect people of any skin tone. The signs and symptoms of melanoma include a large brownish spot with darker speckles, a mole that changes in color, size or feel, a small lesion with an irregular border and portions that appear red, white, blue or blue-black.

The research team can display an increase in metabolic turnover in melanoma — this high turnover of energy results in abnormal acidification of the tumor environment. Due to the rise in an acidic environment, macrophages – the immune cells employed in anti-inflammation – develop into M2 macrophages, a sub-type of the anti-inflammatory molecule involved in the regeneration of tissue damage. This new development, interestingly, now assists in the survival of the cancer cells.

The team identifies a protein known as inducible cAMP early repressor (ICER). ICER is a protein that allows to the normal macrophages to develop into the MD sub-type macrophages.

By way of an animal model and through human tissue samples the team can prove their findings. "In an animal model we were further able to prove that the immune response to tumors is boosted or, in other words, the growth of cancer is slowed, if we eliminate ICER or interrupt the corresponding signal pathway," explains one of the scientists. "Comparable results obtained in analogous experiments using human tissue as samples underline the clinical relevance of our findings."

The team of researchers has successfully aided in the overall knowledge of how melanoma can effectively evade elimination by making use of the immune mechanisms that promote their survival in this example. The team hopes this knowledge will be used in future studies to combat cancer.

Sources: Nature Immunology, Science Daily, Mayo Clinic, YouTube

About the Author
You May Also Like
AUG 13, 2020
Immunology
Antibiotics Now, Inflammatory Bowel Disease Later
AUG 13, 2020
Antibiotics Now, Inflammatory Bowel Disease Later
Taking a course of antibiotics as a baby has been linked to a spiked risk of developing inflammatory bowel disease in ad ...
AUG 24, 2020
Immunology
Injectable Drug Stops HIV From Entering Cells
AUG 24, 2020
Injectable Drug Stops HIV From Entering Cells
Once in the body, HIV tracks down T cells that bear the CD4 receptor. It attaches to these immune cells, fusing itself w ...
NOV 02, 2020
Immunology
New Cancer Drug Reboots Stalled Immunotherapies
NOV 02, 2020
New Cancer Drug Reboots Stalled Immunotherapies
In contrast to traditional chemotherapies, immunotherapies reprogram the patient’s own immune system to fight tumo ...
NOV 09, 2020
Microbiology
Fighting COVID-19 with Help From Llamas
NOV 09, 2020
Fighting COVID-19 with Help From Llamas
Camelids, which include llamas, alpacas and camels have immune systems that generate two kinds of antibodies when confro ...
NOV 12, 2020
Immunology
The Enzyme That Keeps Viruses In Stealth Mode
NOV 12, 2020
The Enzyme That Keeps Viruses In Stealth Mode
Some viral infections just don’t go away. The hepatitis C virus, for instance, can result in life-long chronic inf ...
NOV 24, 2020
Immunology
Dirty Sheets Make Babies Healthier
NOV 24, 2020
Dirty Sheets Make Babies Healthier
Microbiologists have established that the development of infants’ immune systems is intricately linked to the dive ...
Loading Comments...